Vivo Biotech
Vivo Biotech Share Price Chart
Vivo Biotech last traded at ₹14.50 (2026-10-13). Over the past month the stock moved -15.5%, three months the stock moved -46.7%, year the stock moved -62.8%. Its closing range over 52 weeks is ₹13.84 – ₹37.39, with the latest close 61.2% below the high.
Closing prices up to 2026-10-13.
About Vivo Biotech
Incorporated in 1987, Vivo Bio Tech Ltd is engaged in service of CRO offering Drug Development & Discovery Services to Pharmaceutical & Biotech Companies[1]
Business Overview:[1] VBTL is a full-service preclinical contract research organisation (CRO) and specific pathogen free (SPF) laboratory animal breeder offering drug development and discovery services to pharmaceutical and biotech companies world-wide in accordance with OECD – GLP having applicability in OECD member countries and is accredited by AAALAC International. VBTL offers services in the areas of in-vitro, in-vivo, toxicity studies, pharmacological investigations, etc.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Vivo Biotech reported sales of ₹14.28 crore (+14.1%) and net profit of ₹0.19 crore (-85.8%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 14.28 | 5.05 | 35.36 | 0.19 | 0.09 |
| Mar 2026 | 14.20 | 4.45 | 31.34 | -5.16 | -2.33 |
| Dec 2025 | 13.51 | 5.49 | 40.64 | 1.25 | 0.57 |
| Sep 2025 | 13.11 | 5.42 | 41.34 | 0.87 | 0.39 |
| Jun 2025 | 12.51 | 5.48 | 43.80 | 1.34 | 0.67 |
| Mar 2025 | 12.29 | 5.02 | 40.85 | 1.06 | 0.62 |
| Dec 2024 | 12.21 | 5.54 | 45.37 | 0.82 | 0.51 |
| Sep 2024 | 12.04 | 5.59 | 46.43 | 5.23 | 3.51 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +30.0% | -5.0% | +4.5% | +23.5% | +8.9% | +10.6% | +15.5% | +14.1% |
| Operating profit growth | +15.0% | -13.0% | -6.5% | +25.7% | -3.0% | -0.9% | -11.4% | -7.8% |
| Net profit growth | +1484.8% | -37.9% | +43.2% | +688.2% | -83.4% | +52.4% | -586.8% | -85.8% |
| EPS growth | +1495.5% | -42.7% | +24.0% | +509.1% | -88.9% | +11.8% | -475.8% | -86.6% |
| OPM % | 46.4% | 45.4% | 40.9% | 43.8% | 41.3% | 40.6% | 31.3% | 35.4% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Vivo Biotech reported sales of ₹53.33 crore (+14.3%) and net profit of ₹-1.71 crore (-123.5%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 53.33 | 20.85 | 39.10 | -1.71 | -0.77 |
| Mar 2025 | 46.67 | 20.51 | 43.95 | 7.28 | 4.24 |
| Mar 2024 | 45.45 | 21.26 | 46.78 | 2.53 | 1.70 |
| Mar 2023 | 52.23 | 21.84 | 41.82 | 2.65 | 1.78 |
| Mar 2022 | 51.39 | 16.09 | 31.31 | 2.20 | 1.54 |
| Mar 2021 | 51.78 | 17.80 | 34.38 | 5.68 | 4.23 |
| Mar 2020 | 55.35 | 12.47 | 22.53 | 4.44 | 3.45 |
| Mar 2019 | 55.83 | 9.51 | 17.03 | 2.25 | 1.82 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +18.8% | -0.9% | -6.4% | -0.8% | +1.6% | -13.0% | +2.7% | +14.3% |
| Operating profit growth | -12.7% | +31.1% | +42.7% | -9.6% | +35.7% | -2.7% | -3.5% | +1.7% |
| Net profit growth | -27.9% | +97.3% | +27.9% | -61.3% | +20.5% | -4.5% | +187.7% | -123.5% |
| EPS growth | -42.6% | +89.6% | +22.6% | -63.6% | +15.6% | -4.5% | +149.4% | -118.2% |
| OPM % | 17.0% | 22.5% | 34.4% | 31.3% | 41.8% | 46.8% | 44.0% | 39.1% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Vivo Biotech.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Vivo Biotech.
Frequently Asked Questions
What is Vivo Biotech's current stock price?
Vivo Biotech shares were last quoted at ₹14.50 (-2.6% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Vivo Biotech?
Vivo Biotech has a price-to-earnings (P/E) ratio of -11.84 and a price-to-book (P/B) ratio of 0.31. The industry P/E is 25.20.
What is the 52-week high and low of Vivo Biotech?
The 52-week high of Vivo Biotech is ₹38.99 and the 52-week low is ₹15.67.
What is the market cap of Vivo Biotech?
The market capitalisation of Vivo Biotech is about ₹36.91 crore.
How did Vivo Biotech perform in its latest quarterly results?
In the latest quarter (Jun 2026), Vivo Biotech reported sales of ₹14.28 crore (+14.1%) and net profit of ₹0.19 crore (-85.8%), compared with the same quarter last year.
Is Vivo Biotech a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Vivo Biotech has a 3-year ROE of 2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Vivo Biotech?
Promoters hold about 30.62% of Vivo Biotech.
Which sector does Vivo Biotech belong to?
Vivo Biotech belongs to the Biotechnology & Medical Research sector.
Other Biotechnology & Medical Research stocks
- Biocon
- Concord Biotech
- Sun Pharma Advanced Research Company
- Windlas Biotech
- Arvee Laboratories
- Softrak Venture Investment
- ANG Lifesciences India
- Genomic Valley Biotech
All Biotechnology & Medical Research stocks · Browse all stocks A–Z